Basics Harrow Health, Inc. Common Stock IPO Date: October 1, 2007 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $1.69B Activated in VL: True Average Daily Range Avg Daily Range: $0.50 | 2.73% Avg Daily Range (30 D): $1.07 | 2.81% Avg Daily Range (90 D): $1.06 | 2.71% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .57M Avg Daily Volume (90 D): .62M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 51 Institutional Trades Total Inst.Trades: 731 Avg Inst. Trade: $1.74M Avg Inst. Trade (30 D): $1.49M Avg Inst. Trade (90 D): $1.67M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.91M Avg Closing Trade (30 D): $1.78M Avg Closing Trade (90 D): $2.05M Avg Closing Volume: 72.56K     News Nov 27, 2025 @ 3:15 PM Penn Capital Unwinds $17.1 Million BGC Stake as Br... Source: Jonathan Ponciano Sep 26, 2025 @ 12:57 PM Could Harrow's New Sedation Pill Change Millions O... Source: Triveni Kothapalli Sep 26, 2025 @ 11:00 AM Harrow to Acquire Melt Pharmaceuticals Source: Not Specified Sep 8, 2025 @ 9:57 PM Harrow Announces Pricing of $250.0 Million Offerin... Source: Mike Biega Sep 8, 2025 @ 12:00 PM Harrow Announces Offering of $250.0 Million Senior... Source: Mike Biega Financials   TTM Q2 2025 Q1 2025 Basic EPS $.03 $.14 $-.5 Diluted EPS $.03 $.13 $-.5 Revenue $ 71.64M $ 63.74M $ 47.83M Gross Profit $ 53.93M $ 47.51M $ 32.31M Net Income / Loss $ 1.02M $ 5M $ -17.78M Operating Income / Loss $ 14.75M $ 11.41M $ -11.23M Cost of Revenue $ 17.71M $ 16.23M $ 15.52M Net Cash Flow $ 21.33M $ -13.76M $ 19.48M PE Ratio 1,519.83     Splits Feb 08, 2013:   1:5